Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30,767,343
-
Total 13F shares
-
3,165,674
-
Share change
-
-146,164
-
Total reported value
-
$16,936,156
-
Put/Call ratio
-
98%
-
Price per share
-
$5.35
-
Number of holders
-
42
-
Value change
-
-$782,940
-
Number of buys
-
14
-
Number of sells
-
20
Institutional Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2018
As of 31 Mar 2018,
XBiotech Inc. - Common Shares, no par value (XBIT) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,165,674 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, SCHWAB CHARLES INVESTMENT MANAGEMENT INC, Bank of New York Mellon Corp, CREDIT SUISSE AG/, TIAA CREF INVESTMENT MANAGEMENT LLC, and ALLIANCEBERNSTEIN L.P..
This page lists
42
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.